SlideShare a Scribd company logo
1 of 57
Download to read offline
1
Get the SKOOP:
Skills and Knowledge on
Overdose Prevention
William Matthews, RPA-C
Sharon Stancliff, MD
Harm Reduction Coalition
November 2010
Get the SKOOP: overdose prevention  - Bill Matthews - HRC 2010
Get the SKOOP: overdose prevention  - Bill Matthews - HRC 2010
4
What is the most dispensed
prescription drug in the United
States?
(number of prescriptions filled;
generic and branded products, 2004-06)
4
5
Top 10 Drugs Dispensed in
2006
1.
Hydrocodone/Acetaminophen(Vic
odin)
2. Lipitor®
3. Amoxicillin
4. Lisinopril
5. Hydrochlorothiazide
6. Atenolol
7. Zithromax®
8. Furosemide
9. Alprazolam (Xanax)
10. Toprol-XL®
Source: http://www.rxlist.com/script/main/hp.asp 5
6
Opioid treatment admissions:
1999-2009 ages 12-24
0
2000
4000
6000
8000
10000
12000
14000
16000
NYC NYS
1999
2004
2009
NYS OASAS Data Warehouse
7
Death Rates for the Three Leading Causes of
Injury Death 1979--2007
CDC Morbidity and Mortality Weekly Report, August 6, 2010
8
Motor-Vehicle & Poisoning Death Rates,
2005- 2006
• Among adults aged 34-56 years, poisoning death rates were higher than
motor –vehicle traffic death rates.
• 92% of poisoning deaths involved drugs.
National Vital Statistics System, mortality data, http://www.cdc.gov/nchs/deaths.htm.
9
Injection drug and heroin use: 2006
New York City
Estimates
150- 200,000 heroin users, at least 50%
of whom inject regularly
• 108,500 injection drug users
• Unknown number of prescription opioid
users
Frank MSJM 2000, Friedman 2005, Des Jarlais – personal communication
10
Heroin Overdose
Epidemiology
About 2% of heroin users die each year- many
from heroin overdose
New York City, 2006: 979 OD deaths (70% due to
opioids) = ~ 685 opioid deaths
Up to 2/3 of heroin users experience at least one
nonfatal overdose
Sporer BMJ 2002, Galea 2003, Coffin Acad Emerg Med 2007
11
What do we know about
overdose?
12
Who overdoses?
• Happens most often in dependent long
term users with 5- 10 years of experience
rather than new users
Sporer 2003, 2006
Get the SKOOP: overdose prevention  - Bill Matthews - HRC 2010
14
Physiology
• Generally happens over course of 1-3 hours-
the stereotype “needle in the arm” death is
only about 15%
• Opioids repress the urge to breath –
decrease response to carbon dioxide -leading
to respiratory depression and death
Slow breathing>Breathing stops>Heart
stops>Circulation of blood to the brain stops
15
Context of Opioid Overdose
• The majority of overdoses are witnessed
(gives an opportunity for intervention)
• Fear of police may prevent calling 911
• Witnesses may try ineffectual things
– Myths and lack of proper training
– Abandonment is the worst response
Tracy 2005
16
An Antidote exists
• Naloxone (Narcan) is an opioid antagonist
which reverses the effects of opioids
preventing fatal overdose
• Pushes most other opioids off the opioid
receptors and continues to blocks them for
30-90 minutes
17
Legal Status- New Overdose Law in
New York State (Effective April 1,
2006)
• Protects the non-medical person who administers
naloxone in setting of overdose from liability.
– “shall be considered first aid or emergency
treatment”.
– “shall not constitute the unlawful practice of a
profession”.
• Allows the medical provider to provide naloxone for
secondary administration.
• NYSDOH created regulations for implementation of
opioid overdose prevention programs.
• Naloxone must be dispensed by MD, PA, NP by
federal regulation
18
Components of Opioid Overdose
Prevention Training
• What is naloxone?
• What are opioids?
• Prevention and understanding risk factors:
• Overdose recognition
• Action Call 911
– Rescue breathing- using dummy
– Naloxone administration and how it works
– Recovery position
• Report and get refill
• Legality
19
What are opioids?
• heroin
• morphine
• codeine
• methadone
• oxycodone
– OxyContin
– Percodan
– Percocet
• hydrocodone
– Vicodin
• fentanyl
• hydromorphone
– Dilaudid
Papaver
Somniferum
“Poppy
Plant”
20
What are the Risk Factors
for Opioid Overdose?
21
Risk Factors for Opioid
Overdose
• Reduced
Tolerance
• Illness
• Depression
• Unstable housing
• Mixing Drugs
• Changes in the Drug
Supply
• History of previous
overdose
• Using in a new
environment
Overdose deaths in New York
City involve multiple drugs
(2008)
Nearly all unintentional drug overdose deaths (98%)
involve more than one substance, including alcohol.
Opioids were the most commonly noted drug type
(74%). Types of opioids included heroin,
methadone, and prescription pain relievers.
Other drugs commonly found were: cocaine (53%),
benzodiazepines (35%), antidepressants (26%),
and alcohol (43%).
NYC VITAL SIGNS Volume 9, No. 1, NYCDOHMH
23
Lowered tolerance: Major risk
• Tolerance- repeated use of a substance may
lead to the need for increased amounts to
product the same effect
• Abstinence decreases tolerance increasing
overdose risk
– Incarceration
– Hospitalization
– Drug treatment/ Detox/ Therapeutic communities
– Sporatic patterns of drug use
– Sporer 2007, Binswanger 2007
24
Risk factor: Overdose Death
following Incarceration
Cause of Death in the 2 weeks post-
incarceration
Washington State Corrections – studied 30,237 inmates
released (7/99-12/03)
Former Inmates were:
– 12.7 times more likely to die vs. WS residents of same
age, race, and sex
– 129 times more likely to die of overdose vs WS residents
• Opioids: 60%
• Cocaine and other stimulants: 74%
• Binswanger et al., 2007
25
Other risk factors
• Significant illness
• Major changes in opioid supply/
Variations in strength of street drugs
>1000 deaths USA 2006 with fentanyl
• Depression
• History of previous overdose
• Injection drug use
• Using alone increases risk of death
Sporer 2006, Wines 2007, Pollini 2006
http://www.whitehousedrugpolicy.gov/news/fentnyl%5Fheroin%5Ff
orum,
26
What does an Opioid
Overdose Look Like?
27
Continuum of Overdose
• Overdose is rarely immediate – can happen
over 1-3 hours
• Heavy/ Uncontrollable Nodding
– Still arousable
– Snoring or loud breathing
– May have excess drooling
• Overdose
– Not responsive
– Very shallow breathing, gurgling
– Skin changes, blue lips and nails
• Fatal Overdose
28
Recognition
• Opioid overdose happens over time
• Blue lips and nail beds
• Slow or no breathing, gurgling, snorting
sound
• Not responsive*
29
Stimulate the person overdosing
• Shake, call name loudly
• Sternal rub: rub knuckles hard up and
down breast bone (it hurts!)
(Ice can work but this is easier)
30
Step One: Get Help
• Call 911- “My friend is unconscious/not
breathing”
• This phrase is more likely to bring
paramedics with naloxone than EMT, who
don’t carry it
• Give location
• No need to say “overdose”
• Police may come
31
Check for breathing
• Chest rising and falling
• Nostrils moving in and out
• Mirror or glass by nose or mouth will fog
up
32
Step Two: Rescue breathing
Rescue breathing alone can sustain
someone until EMS arrives
Mouth to mouth is
using a dummy for
practice (if available)
Chest compressions not
included (unless
Responder is trained
in CPR)
33
Rescue Breathing
• Tilt back head to open airway
• Hold nose, lift chin
• Make a seal over the mouth with your
mouth
• Start with 2 quick breaths then one breath
about every 5 seconds until EMS arrives
or person breathes on their own.
34
Naloxone preparations
• Injectable
– Inexpensive: $2 - 3.00 per dose
– Well-documented efficacy
– Requires injection, drawing from a medical
vial into a syringe
• Intranasal
– More expensive: $19.25 per dose
– Less well-documented efficacy
– Requires assembly of spay device with nasal
adaptor and naloxone capsule
35
The injectable kit contains:
• A face mask for rescue breathing
• Two safety syringes
• 2 vials of Naloxone
• 2 alcohol swabs
• 2 latex gloves
• 1 brochure reviewing OD and rescue
steps.
• Contact information for program
36
Administration of Naloxone
• Inject into a muscle
or
spray up nose
• Acts within 2-8 minutes
• If no response in 2-5 minutes, give 2nd
dose
• Lasts for 30 – 90 minutes
• (reminder that if 911 has not been called
do it now!!)
37
Recovery Position
• If you must leave the overdoser even for
a few minutes put them into the
recovery position so they won’t
choke on vomit
38
Naloxone in Action
• Reverses opiate effect of sedation and
respiratory depression
• Causes sudden withdrawal in the opioid
dependent person – an unpleasant
experience
• No psychoactive effects – low potential for
diversion, is not addictive
• Routinely used by EMS (but in larger
doses)
• Has no effect if an opiate is not present
• Sold over the counter in Italy
39
More about Naloxone
• It is regulated but not a controlled
substance
• Need to obtain from a licensed prescriber
• Should be stored at room temperature and
away from direct light (in kit is OK)
• Has a limited shelf life. Note expiration
date and obtain replacement
40
Results: awake and breathing
Narcan wears off in 30-90 minutes
• Don’t leave the overdoser alone as
sedation may return
• Reassure the overdoser if s/he is drug
sick- the naloxone will wear off- don’t use
more heroin to feel better!!
• Encourage survivor to go to the hospital
41
Safety in the field
Over 3,500 kits distributed
319 overdose reversals reported
• 1 unsuccessful revival
• 1 seizure
• 1 vomited
• Only 5 cases with more than 1 injection
• No cases of re-treatment after naloxone wore off
• Maxwell 2006
42
Trained Overdose Responder
Responsibilities
• Complete initial opioid overdose
prevention training
• Complete refresher training at least every
2 years
• Contact EMS if suspected drug overdose
and advise if naloxone was used
• Report all opioid overdose responses/
naloxone administration to program
director and get a refill
43
HRC initiative
• 2004 Tides grant: Trained over 90 participants at
one SEP
• 2005 – 2010 NYCDOHMH grant
– > 5,000 participants trained as overdose
responders and provided with overdose rescue kits
– Primarily at 14 syringe exchange programs, now
expanding to CBOs
About 350 overdose reversals reported to date
(10/10)
2010 NOPE Survey of naloxone
distribution in US since 1996
• 53,339 kits dispensed
• 10, 194 overdose reversals reported
• 2010: Distribution from 155 sites in 16
states
• 38,860 units of naloxone dispensed
7/09 – 6/10
• Types of naloxone: 42% 1 mL vials, 67%
10 mL vials, 17% 2 mL Intranasal
Naloxone Overdose Prevention, Education (NOPE)
Eliza Wheeler <wheeler@harmreduction.org>
44
45
Number and rate per 100,000 New Yorkers of
unintentional drug overdose deaths 1999-2008
663 675
666
749
874
812
778
827
766
799
9.7
11.1
13.2
12.4
12
12.7
11.9
12.5
10.6
10.5
0
100
200
300
400
500
600
700
800
900
1000
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Number
of
unintentioanl
drug
overdose
deaths
0
2
4
6
8
10
12
14
Age-adjusted
mortality
rate
per
100,000
population
Number of unintentional drug overdose deaths
Age-adjusted unintentional drug overdose death rates per 100,000 New Yorkers
Source: Bureau of Vital Statistics NYC DOHMH, 1999-2008; 2008 data are preliminary
Effect of naloxone on overdose
death: Chicago, US
47
Experience in other US cities
• Population-level changes in mortality already
observable in some cities:
• 34% reduction in countywide fatal overdoses in
Cook County, IL, (Chicago) from 1999 – 2003
• 19% reduction in city-wide overdose fatalities in
Baltimore after the program’s first year of
operation
• San Francisco: 2,235 kits dispensed, 501
reversals, from 2003 – August, 2010.
• Scott, 2007; 3/28/05 Baltimore Sun; DOPE Project, reported by Eliza Wheeler, 9/10
Heroin overdoses dropping
Allegheny County Trends in Accidental Drug Overdose Deaths
2000-2006*
*Data is from Allegheny County Medical Examiners Annual Reports and includes all
overdose deaths where these drugs were present at time of death, not necessarily cause of
death.
Heroin Use in Allegheny County by Fiscal
Year
*Data from Pennsylvania Department Of Health
50
To receive a kit
• A medical professional must dispense the
naloxone kits. (Naloxone is regulated like
any other medication but is not a
controlled substance.)
• This requires a very brief medical history.
• Prescribers will usually give a prescription
saying naloxone and syringes“dispensed”
to keep in the kit.
51
Who may offer an Opioid
Overdose Prevention Program?
• Licensed health care
facilities :
– Hospitals
– Diagnostic & Treatment
Centers
• Drug treatment programs
• Health care practitioners:
– Physicians
– Physician assistants
– Nurse practitioners
• CBOs with the services of
a clinical director
• Local health departments
52
Overdose Program
Requirements
• Register with NYSDOH, update info
• Have P&P and training curriculum
• Keep log of trained OD responders,and
dates of trainings
• Have list of staff doing OD trainings
• Medical provider when naloxone given
• Send OD reversal reports to NYSDOH
and keep copy
53
Overdose Program Staff
• Overdose Program Director- required
• Overdose Clinical Director- required
• Physician
• Physician assistant
• Nurse practitioner
• Affiliated prescribers, who must be physicians,
physician assistants or nurse practitioners
• Overdose Prevention Trainers
54
Available resources
• Naloxone kits (free from NYSDOH)
• Sample policies and procedures
• Approved curriculum
• Fact sheets
• Sample medical history
• Certificates of completion
• OD reporting form
55
Conclusions
• Many overdoses can be prevented
• Ask about risk factors and educate patients
• Overdose training consists of a few basic
components
• Integrate into intake, medical visits and patient care
• Drug users, friends, and family can learn to
prevent and safely treat overdose
• Goals:
• Overdose training as standard of care
• Naloxone available over the counter
56
RESOURCES
• Harm Reduction Coalition
(harmreduction.org)
NYSDOH(www.health.state.ny.us -
search for overdose)
• On-line CASAC training and credit
– www.oasas.state.ny.us
Harm Reduction Coalition
stancliff@harmreduction.org
212-213-6376 ext 39
matthews@harmreduction.org
ext 38
57

More Related Content

Viewers also liked

Wed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_externalWed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_externalOPUNITE
 
Dangling modifiers
Dangling modifiersDangling modifiers
Dangling modifiersumalariam
 
Cancer immunotherapy
Cancer immunotherapyCancer immunotherapy
Cancer immunotherapykhehkesha
 
Immunotherapy workshop
Immunotherapy workshopImmunotherapy workshop
Immunotherapy workshopHiba Ashibany
 
Acute poisoning guidelines for initial management
Acute poisoning   guidelines for initial managementAcute poisoning   guidelines for initial management
Acute poisoning guidelines for initial managementDr. Saad Saleh Al Ani
 
Learn BEM: CSS Naming Convention
Learn BEM: CSS Naming ConventionLearn BEM: CSS Naming Convention
Learn BEM: CSS Naming ConventionIn a Rocket
 
Different types of immunotherapy for lung cancer treatment
Different types of immunotherapy for lung cancer treatmentDifferent types of immunotherapy for lung cancer treatment
Different types of immunotherapy for lung cancer treatmentlee shin
 

Viewers also liked (20)

Item Analysis
Item AnalysisItem Analysis
Item Analysis
 
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_externalWed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
 
Ovarian cancer (ctump Medical English presentation)
Ovarian cancer (ctump Medical English presentation)Ovarian cancer (ctump Medical English presentation)
Ovarian cancer (ctump Medical English presentation)
 
Drug overdose poisoning
Drug overdose poisoningDrug overdose poisoning
Drug overdose poisoning
 
Dangling modifiers
Dangling modifiersDangling modifiers
Dangling modifiers
 
Drug overdose in general
Drug overdose in generalDrug overdose in general
Drug overdose in general
 
Drug Poisoning
Drug Poisoning Drug Poisoning
Drug Poisoning
 
Immunotherapy
Immunotherapy Immunotherapy
Immunotherapy
 
Immunotherapy
ImmunotherapyImmunotherapy
Immunotherapy
 
Item Analysis
Item AnalysisItem Analysis
Item Analysis
 
Acute poisoning
Acute poisoningAcute poisoning
Acute poisoning
 
Cancer immunotherapy
Cancer immunotherapyCancer immunotherapy
Cancer immunotherapy
 
Immunotherapy workshop
Immunotherapy workshopImmunotherapy workshop
Immunotherapy workshop
 
Acute poisoning guidelines for initial management
Acute poisoning   guidelines for initial managementAcute poisoning   guidelines for initial management
Acute poisoning guidelines for initial management
 
Cancer immunotherapy
Cancer immunotherapyCancer immunotherapy
Cancer immunotherapy
 
Paracetamol overdose
Paracetamol overdoseParacetamol overdose
Paracetamol overdose
 
Item analysis ppt
Item analysis pptItem analysis ppt
Item analysis ppt
 
Item analysis
Item analysis Item analysis
Item analysis
 
Learn BEM: CSS Naming Convention
Learn BEM: CSS Naming ConventionLearn BEM: CSS Naming Convention
Learn BEM: CSS Naming Convention
 
Different types of immunotherapy for lung cancer treatment
Different types of immunotherapy for lung cancer treatmentDifferent types of immunotherapy for lung cancer treatment
Different types of immunotherapy for lung cancer treatment
 

Similar to Get the SKOOP: overdose prevention - Bill Matthews - HRC 2010

OEND pharmacist slides - updated 9.3.2016-2
OEND pharmacist slides - updated 9.3.2016-2OEND pharmacist slides - updated 9.3.2016-2
OEND pharmacist slides - updated 9.3.2016-2Rafael Otero De Santiago
 
Ct ems naloxone_bls_training_27may2014 PPT
Ct ems naloxone_bls_training_27may2014 PPTCt ems naloxone_bls_training_27may2014 PPT
Ct ems naloxone_bls_training_27may2014 PPTcmarth
 
Ems world expo naloxone 11112014.handout
Ems world expo naloxone 11112014.handoutEms world expo naloxone 11112014.handout
Ems world expo naloxone 11112014.handoutMichael Dailey
 
Overdose awareness and harm reduction
Overdose awareness and harm reductionOverdose awareness and harm reduction
Overdose awareness and harm reductionHomewardBound
 
Ct ems naloxone_bls_training_27may2014 (2)
Ct ems naloxone_bls_training_27may2014 (2)Ct ems naloxone_bls_training_27may2014 (2)
Ct ems naloxone_bls_training_27may2014 (2)dinterlandi
 
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency Department
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency DepartmentTackling the Opioid Problem - Analgesic Prescribing in the Emergency Department
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency DepartmentSCGH ED CME
 
Rx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_groupRx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_groupOPUNITE
 
Naloxone presentation for Idaho Board of Pharmacy 2
Naloxone presentation for Idaho Board of Pharmacy 2Naloxone presentation for Idaho Board of Pharmacy 2
Naloxone presentation for Idaho Board of Pharmacy 2Robert Cole
 
Otc Naloxone Research Papers
Otc Naloxone Research PapersOtc Naloxone Research Papers
Otc Naloxone Research PapersSummer Young
 
Narcan nasal spray FINAL
Narcan nasal spray FINALNarcan nasal spray FINAL
Narcan nasal spray FINALDien Vu
 
Preventing most overdose deaths would be easy So, why don’t we?
Preventing most overdose deaths would be easy  So, why don’t we?Preventing most overdose deaths would be easy  So, why don’t we?
Preventing most overdose deaths would be easy So, why don’t we?IDHDP
 
Acp - ce -2016 08 update- smack is wack
Acp - ce -2016 08 update- smack is wackAcp - ce -2016 08 update- smack is wack
Acp - ce -2016 08 update- smack is wackRobert Cole
 
The Neuroscience of Drug Addiction and Therapy
The Neuroscience of Drug Addiction and TherapyThe Neuroscience of Drug Addiction and Therapy
The Neuroscience of Drug Addiction and Therapyyvettelopez21
 
Drug Addiction Pharmacology Information.
Drug Addiction Pharmacology Information.Drug Addiction Pharmacology Information.
Drug Addiction Pharmacology Information.yvettelopez21
 
understanding-Opioid-Crisis-using-decision-heuristics-science.pdf
understanding-Opioid-Crisis-using-decision-heuristics-science.pdfunderstanding-Opioid-Crisis-using-decision-heuristics-science.pdf
understanding-Opioid-Crisis-using-decision-heuristics-science.pdfNewristics USA
 
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB Policy
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB PolicyPreventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB Policy
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB PolicyPASaskatchewan
 
Neuropharmacological Treatments of Drug Addiction
Neuropharmacological Treatments of Drug AddictionNeuropharmacological Treatments of Drug Addiction
Neuropharmacological Treatments of Drug AddictionBrian Piper
 
Life Won't Wait Capstone Presentation - final presentation
Life Won't Wait Capstone Presentation - final presentationLife Won't Wait Capstone Presentation - final presentation
Life Won't Wait Capstone Presentation - final presentationJordan Westfall
 
Phil Walls
Phil WallsPhil Walls
Phil WallsOPUNITE
 

Similar to Get the SKOOP: overdose prevention - Bill Matthews - HRC 2010 (20)

OEND pharmacist slides - updated 9.3.2016-2
OEND pharmacist slides - updated 9.3.2016-2OEND pharmacist slides - updated 9.3.2016-2
OEND pharmacist slides - updated 9.3.2016-2
 
Ct ems naloxone_bls_training_27may2014 PPT
Ct ems naloxone_bls_training_27may2014 PPTCt ems naloxone_bls_training_27may2014 PPT
Ct ems naloxone_bls_training_27may2014 PPT
 
Ems world expo naloxone 11112014.handout
Ems world expo naloxone 11112014.handoutEms world expo naloxone 11112014.handout
Ems world expo naloxone 11112014.handout
 
Overdose awareness and harm reduction
Overdose awareness and harm reductionOverdose awareness and harm reduction
Overdose awareness and harm reduction
 
Ct ems naloxone_bls_training_27may2014 (2)
Ct ems naloxone_bls_training_27may2014 (2)Ct ems naloxone_bls_training_27may2014 (2)
Ct ems naloxone_bls_training_27may2014 (2)
 
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency Department
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency DepartmentTackling the Opioid Problem - Analgesic Prescribing in the Emergency Department
Tackling the Opioid Problem - Analgesic Prescribing in the Emergency Department
 
Rx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_groupRx16 vs ukhealthcare_800_group
Rx16 vs ukhealthcare_800_group
 
Naloxone presentation for Idaho Board of Pharmacy 2
Naloxone presentation for Idaho Board of Pharmacy 2Naloxone presentation for Idaho Board of Pharmacy 2
Naloxone presentation for Idaho Board of Pharmacy 2
 
Otc Naloxone Research Papers
Otc Naloxone Research PapersOtc Naloxone Research Papers
Otc Naloxone Research Papers
 
Narcan nasal spray FINAL
Narcan nasal spray FINALNarcan nasal spray FINAL
Narcan nasal spray FINAL
 
Preventing most overdose deaths would be easy So, why don’t we?
Preventing most overdose deaths would be easy  So, why don’t we?Preventing most overdose deaths would be easy  So, why don’t we?
Preventing most overdose deaths would be easy So, why don’t we?
 
Acp - ce -2016 08 update- smack is wack
Acp - ce -2016 08 update- smack is wackAcp - ce -2016 08 update- smack is wack
Acp - ce -2016 08 update- smack is wack
 
The Neuroscience of Drug Addiction and Therapy
The Neuroscience of Drug Addiction and TherapyThe Neuroscience of Drug Addiction and Therapy
The Neuroscience of Drug Addiction and Therapy
 
Drug Addiction Pharmacology Information.
Drug Addiction Pharmacology Information.Drug Addiction Pharmacology Information.
Drug Addiction Pharmacology Information.
 
understanding-Opioid-Crisis-using-decision-heuristics-science.pdf
understanding-Opioid-Crisis-using-decision-heuristics-science.pdfunderstanding-Opioid-Crisis-using-decision-heuristics-science.pdf
understanding-Opioid-Crisis-using-decision-heuristics-science.pdf
 
Opioid-Epidemic.pdf
Opioid-Epidemic.pdfOpioid-Epidemic.pdf
Opioid-Epidemic.pdf
 
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB Policy
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB PolicyPreventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB Policy
Preventing Opioid Overdose Deaths with Take-home Naloxone/ NIHB Policy
 
Neuropharmacological Treatments of Drug Addiction
Neuropharmacological Treatments of Drug AddictionNeuropharmacological Treatments of Drug Addiction
Neuropharmacological Treatments of Drug Addiction
 
Life Won't Wait Capstone Presentation - final presentation
Life Won't Wait Capstone Presentation - final presentationLife Won't Wait Capstone Presentation - final presentation
Life Won't Wait Capstone Presentation - final presentation
 
Phil Walls
Phil WallsPhil Walls
Phil Walls
 

More from Harm Reduction Coalition

Countdown: confronting the HIV/HCV coinfection crisis
Countdown:  confronting the HIV/HCV coinfection crisisCountdown:  confronting the HIV/HCV coinfection crisis
Countdown: confronting the HIV/HCV coinfection crisisHarm Reduction Coalition
 
Countdown: Confronting the HIV/HCV Coinfection Crisis
Countdown: Confronting the HIV/HCV Coinfection CrisisCountdown: Confronting the HIV/HCV Coinfection Crisis
Countdown: Confronting the HIV/HCV Coinfection CrisisHarm Reduction Coalition
 
Harm reduction perspective on HHS Viral Hepatitis Action Plan
Harm reduction perspective on HHS Viral Hepatitis Action PlanHarm reduction perspective on HHS Viral Hepatitis Action Plan
Harm reduction perspective on HHS Viral Hepatitis Action PlanHarm Reduction Coalition
 
Working with/in Health Departments to Promote Harm Reduction: Cuellar, McLea...
Working with/in Health Departments to Promote Harm Reduction:  Cuellar, McLea...Working with/in Health Departments to Promote Harm Reduction:  Cuellar, McLea...
Working with/in Health Departments to Promote Harm Reduction: Cuellar, McLea...Harm Reduction Coalition
 
Health Care Reform and Harm Reduction: Laura Hanen, Rachel McLean - HRC 2010
Health Care Reform and Harm Reduction: Laura Hanen, Rachel McLean - HRC 2010Health Care Reform and Harm Reduction: Laura Hanen, Rachel McLean - HRC 2010
Health Care Reform and Harm Reduction: Laura Hanen, Rachel McLean - HRC 2010Harm Reduction Coalition
 

More from Harm Reduction Coalition (6)

Countdown: confronting the HIV/HCV coinfection crisis
Countdown:  confronting the HIV/HCV coinfection crisisCountdown:  confronting the HIV/HCV coinfection crisis
Countdown: confronting the HIV/HCV coinfection crisis
 
Countdown: Confronting the HIV/HCV Coinfection Crisis
Countdown: Confronting the HIV/HCV Coinfection CrisisCountdown: Confronting the HIV/HCV Coinfection Crisis
Countdown: Confronting the HIV/HCV Coinfection Crisis
 
Harm reduction perspective on HHS Viral Hepatitis Action Plan
Harm reduction perspective on HHS Viral Hepatitis Action PlanHarm reduction perspective on HHS Viral Hepatitis Action Plan
Harm reduction perspective on HHS Viral Hepatitis Action Plan
 
Working with/in Health Departments to Promote Harm Reduction: Cuellar, McLea...
Working with/in Health Departments to Promote Harm Reduction:  Cuellar, McLea...Working with/in Health Departments to Promote Harm Reduction:  Cuellar, McLea...
Working with/in Health Departments to Promote Harm Reduction: Cuellar, McLea...
 
Health Care Reform and Harm Reduction: Laura Hanen, Rachel McLean - HRC 2010
Health Care Reform and Harm Reduction: Laura Hanen, Rachel McLean - HRC 2010Health Care Reform and Harm Reduction: Laura Hanen, Rachel McLean - HRC 2010
Health Care Reform and Harm Reduction: Laura Hanen, Rachel McLean - HRC 2010
 
Hepatitis C Prevention - testimony to IOM
Hepatitis C Prevention - testimony to IOMHepatitis C Prevention - testimony to IOM
Hepatitis C Prevention - testimony to IOM
 

Recently uploaded

Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 

Recently uploaded (20)

Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 

Get the SKOOP: overdose prevention - Bill Matthews - HRC 2010

  • 1. 1 Get the SKOOP: Skills and Knowledge on Overdose Prevention William Matthews, RPA-C Sharon Stancliff, MD Harm Reduction Coalition November 2010
  • 4. 4 What is the most dispensed prescription drug in the United States? (number of prescriptions filled; generic and branded products, 2004-06) 4
  • 5. 5 Top 10 Drugs Dispensed in 2006 1. Hydrocodone/Acetaminophen(Vic odin) 2. Lipitor® 3. Amoxicillin 4. Lisinopril 5. Hydrochlorothiazide 6. Atenolol 7. Zithromax® 8. Furosemide 9. Alprazolam (Xanax) 10. Toprol-XL® Source: http://www.rxlist.com/script/main/hp.asp 5
  • 6. 6 Opioid treatment admissions: 1999-2009 ages 12-24 0 2000 4000 6000 8000 10000 12000 14000 16000 NYC NYS 1999 2004 2009 NYS OASAS Data Warehouse
  • 7. 7 Death Rates for the Three Leading Causes of Injury Death 1979--2007 CDC Morbidity and Mortality Weekly Report, August 6, 2010
  • 8. 8 Motor-Vehicle & Poisoning Death Rates, 2005- 2006 • Among adults aged 34-56 years, poisoning death rates were higher than motor –vehicle traffic death rates. • 92% of poisoning deaths involved drugs. National Vital Statistics System, mortality data, http://www.cdc.gov/nchs/deaths.htm.
  • 9. 9 Injection drug and heroin use: 2006 New York City Estimates 150- 200,000 heroin users, at least 50% of whom inject regularly • 108,500 injection drug users • Unknown number of prescription opioid users Frank MSJM 2000, Friedman 2005, Des Jarlais – personal communication
  • 10. 10 Heroin Overdose Epidemiology About 2% of heroin users die each year- many from heroin overdose New York City, 2006: 979 OD deaths (70% due to opioids) = ~ 685 opioid deaths Up to 2/3 of heroin users experience at least one nonfatal overdose Sporer BMJ 2002, Galea 2003, Coffin Acad Emerg Med 2007
  • 11. 11 What do we know about overdose?
  • 12. 12 Who overdoses? • Happens most often in dependent long term users with 5- 10 years of experience rather than new users Sporer 2003, 2006
  • 14. 14 Physiology • Generally happens over course of 1-3 hours- the stereotype “needle in the arm” death is only about 15% • Opioids repress the urge to breath – decrease response to carbon dioxide -leading to respiratory depression and death Slow breathing>Breathing stops>Heart stops>Circulation of blood to the brain stops
  • 15. 15 Context of Opioid Overdose • The majority of overdoses are witnessed (gives an opportunity for intervention) • Fear of police may prevent calling 911 • Witnesses may try ineffectual things – Myths and lack of proper training – Abandonment is the worst response Tracy 2005
  • 16. 16 An Antidote exists • Naloxone (Narcan) is an opioid antagonist which reverses the effects of opioids preventing fatal overdose • Pushes most other opioids off the opioid receptors and continues to blocks them for 30-90 minutes
  • 17. 17 Legal Status- New Overdose Law in New York State (Effective April 1, 2006) • Protects the non-medical person who administers naloxone in setting of overdose from liability. – “shall be considered first aid or emergency treatment”. – “shall not constitute the unlawful practice of a profession”. • Allows the medical provider to provide naloxone for secondary administration. • NYSDOH created regulations for implementation of opioid overdose prevention programs. • Naloxone must be dispensed by MD, PA, NP by federal regulation
  • 18. 18 Components of Opioid Overdose Prevention Training • What is naloxone? • What are opioids? • Prevention and understanding risk factors: • Overdose recognition • Action Call 911 – Rescue breathing- using dummy – Naloxone administration and how it works – Recovery position • Report and get refill • Legality
  • 19. 19 What are opioids? • heroin • morphine • codeine • methadone • oxycodone – OxyContin – Percodan – Percocet • hydrocodone – Vicodin • fentanyl • hydromorphone – Dilaudid Papaver Somniferum “Poppy Plant”
  • 20. 20 What are the Risk Factors for Opioid Overdose?
  • 21. 21 Risk Factors for Opioid Overdose • Reduced Tolerance • Illness • Depression • Unstable housing • Mixing Drugs • Changes in the Drug Supply • History of previous overdose • Using in a new environment
  • 22. Overdose deaths in New York City involve multiple drugs (2008) Nearly all unintentional drug overdose deaths (98%) involve more than one substance, including alcohol. Opioids were the most commonly noted drug type (74%). Types of opioids included heroin, methadone, and prescription pain relievers. Other drugs commonly found were: cocaine (53%), benzodiazepines (35%), antidepressants (26%), and alcohol (43%). NYC VITAL SIGNS Volume 9, No. 1, NYCDOHMH
  • 23. 23 Lowered tolerance: Major risk • Tolerance- repeated use of a substance may lead to the need for increased amounts to product the same effect • Abstinence decreases tolerance increasing overdose risk – Incarceration – Hospitalization – Drug treatment/ Detox/ Therapeutic communities – Sporatic patterns of drug use – Sporer 2007, Binswanger 2007
  • 24. 24 Risk factor: Overdose Death following Incarceration Cause of Death in the 2 weeks post- incarceration Washington State Corrections – studied 30,237 inmates released (7/99-12/03) Former Inmates were: – 12.7 times more likely to die vs. WS residents of same age, race, and sex – 129 times more likely to die of overdose vs WS residents • Opioids: 60% • Cocaine and other stimulants: 74% • Binswanger et al., 2007
  • 25. 25 Other risk factors • Significant illness • Major changes in opioid supply/ Variations in strength of street drugs >1000 deaths USA 2006 with fentanyl • Depression • History of previous overdose • Injection drug use • Using alone increases risk of death Sporer 2006, Wines 2007, Pollini 2006 http://www.whitehousedrugpolicy.gov/news/fentnyl%5Fheroin%5Ff orum,
  • 26. 26 What does an Opioid Overdose Look Like?
  • 27. 27 Continuum of Overdose • Overdose is rarely immediate – can happen over 1-3 hours • Heavy/ Uncontrollable Nodding – Still arousable – Snoring or loud breathing – May have excess drooling • Overdose – Not responsive – Very shallow breathing, gurgling – Skin changes, blue lips and nails • Fatal Overdose
  • 28. 28 Recognition • Opioid overdose happens over time • Blue lips and nail beds • Slow or no breathing, gurgling, snorting sound • Not responsive*
  • 29. 29 Stimulate the person overdosing • Shake, call name loudly • Sternal rub: rub knuckles hard up and down breast bone (it hurts!) (Ice can work but this is easier)
  • 30. 30 Step One: Get Help • Call 911- “My friend is unconscious/not breathing” • This phrase is more likely to bring paramedics with naloxone than EMT, who don’t carry it • Give location • No need to say “overdose” • Police may come
  • 31. 31 Check for breathing • Chest rising and falling • Nostrils moving in and out • Mirror or glass by nose or mouth will fog up
  • 32. 32 Step Two: Rescue breathing Rescue breathing alone can sustain someone until EMS arrives Mouth to mouth is using a dummy for practice (if available) Chest compressions not included (unless Responder is trained in CPR)
  • 33. 33 Rescue Breathing • Tilt back head to open airway • Hold nose, lift chin • Make a seal over the mouth with your mouth • Start with 2 quick breaths then one breath about every 5 seconds until EMS arrives or person breathes on their own.
  • 34. 34 Naloxone preparations • Injectable – Inexpensive: $2 - 3.00 per dose – Well-documented efficacy – Requires injection, drawing from a medical vial into a syringe • Intranasal – More expensive: $19.25 per dose – Less well-documented efficacy – Requires assembly of spay device with nasal adaptor and naloxone capsule
  • 35. 35 The injectable kit contains: • A face mask for rescue breathing • Two safety syringes • 2 vials of Naloxone • 2 alcohol swabs • 2 latex gloves • 1 brochure reviewing OD and rescue steps. • Contact information for program
  • 36. 36 Administration of Naloxone • Inject into a muscle or spray up nose • Acts within 2-8 minutes • If no response in 2-5 minutes, give 2nd dose • Lasts for 30 – 90 minutes • (reminder that if 911 has not been called do it now!!)
  • 37. 37 Recovery Position • If you must leave the overdoser even for a few minutes put them into the recovery position so they won’t choke on vomit
  • 38. 38 Naloxone in Action • Reverses opiate effect of sedation and respiratory depression • Causes sudden withdrawal in the opioid dependent person – an unpleasant experience • No psychoactive effects – low potential for diversion, is not addictive • Routinely used by EMS (but in larger doses) • Has no effect if an opiate is not present • Sold over the counter in Italy
  • 39. 39 More about Naloxone • It is regulated but not a controlled substance • Need to obtain from a licensed prescriber • Should be stored at room temperature and away from direct light (in kit is OK) • Has a limited shelf life. Note expiration date and obtain replacement
  • 40. 40 Results: awake and breathing Narcan wears off in 30-90 minutes • Don’t leave the overdoser alone as sedation may return • Reassure the overdoser if s/he is drug sick- the naloxone will wear off- don’t use more heroin to feel better!! • Encourage survivor to go to the hospital
  • 41. 41 Safety in the field Over 3,500 kits distributed 319 overdose reversals reported • 1 unsuccessful revival • 1 seizure • 1 vomited • Only 5 cases with more than 1 injection • No cases of re-treatment after naloxone wore off • Maxwell 2006
  • 42. 42 Trained Overdose Responder Responsibilities • Complete initial opioid overdose prevention training • Complete refresher training at least every 2 years • Contact EMS if suspected drug overdose and advise if naloxone was used • Report all opioid overdose responses/ naloxone administration to program director and get a refill
  • 43. 43 HRC initiative • 2004 Tides grant: Trained over 90 participants at one SEP • 2005 – 2010 NYCDOHMH grant – > 5,000 participants trained as overdose responders and provided with overdose rescue kits – Primarily at 14 syringe exchange programs, now expanding to CBOs About 350 overdose reversals reported to date (10/10)
  • 44. 2010 NOPE Survey of naloxone distribution in US since 1996 • 53,339 kits dispensed • 10, 194 overdose reversals reported • 2010: Distribution from 155 sites in 16 states • 38,860 units of naloxone dispensed 7/09 – 6/10 • Types of naloxone: 42% 1 mL vials, 67% 10 mL vials, 17% 2 mL Intranasal Naloxone Overdose Prevention, Education (NOPE) Eliza Wheeler <wheeler@harmreduction.org> 44
  • 45. 45 Number and rate per 100,000 New Yorkers of unintentional drug overdose deaths 1999-2008 663 675 666 749 874 812 778 827 766 799 9.7 11.1 13.2 12.4 12 12.7 11.9 12.5 10.6 10.5 0 100 200 300 400 500 600 700 800 900 1000 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 Number of unintentioanl drug overdose deaths 0 2 4 6 8 10 12 14 Age-adjusted mortality rate per 100,000 population Number of unintentional drug overdose deaths Age-adjusted unintentional drug overdose death rates per 100,000 New Yorkers Source: Bureau of Vital Statistics NYC DOHMH, 1999-2008; 2008 data are preliminary
  • 46. Effect of naloxone on overdose death: Chicago, US
  • 47. 47 Experience in other US cities • Population-level changes in mortality already observable in some cities: • 34% reduction in countywide fatal overdoses in Cook County, IL, (Chicago) from 1999 – 2003 • 19% reduction in city-wide overdose fatalities in Baltimore after the program’s first year of operation • San Francisco: 2,235 kits dispensed, 501 reversals, from 2003 – August, 2010. • Scott, 2007; 3/28/05 Baltimore Sun; DOPE Project, reported by Eliza Wheeler, 9/10
  • 48. Heroin overdoses dropping Allegheny County Trends in Accidental Drug Overdose Deaths 2000-2006* *Data is from Allegheny County Medical Examiners Annual Reports and includes all overdose deaths where these drugs were present at time of death, not necessarily cause of death.
  • 49. Heroin Use in Allegheny County by Fiscal Year *Data from Pennsylvania Department Of Health
  • 50. 50 To receive a kit • A medical professional must dispense the naloxone kits. (Naloxone is regulated like any other medication but is not a controlled substance.) • This requires a very brief medical history. • Prescribers will usually give a prescription saying naloxone and syringes“dispensed” to keep in the kit.
  • 51. 51 Who may offer an Opioid Overdose Prevention Program? • Licensed health care facilities : – Hospitals – Diagnostic & Treatment Centers • Drug treatment programs • Health care practitioners: – Physicians – Physician assistants – Nurse practitioners • CBOs with the services of a clinical director • Local health departments
  • 52. 52 Overdose Program Requirements • Register with NYSDOH, update info • Have P&P and training curriculum • Keep log of trained OD responders,and dates of trainings • Have list of staff doing OD trainings • Medical provider when naloxone given • Send OD reversal reports to NYSDOH and keep copy
  • 53. 53 Overdose Program Staff • Overdose Program Director- required • Overdose Clinical Director- required • Physician • Physician assistant • Nurse practitioner • Affiliated prescribers, who must be physicians, physician assistants or nurse practitioners • Overdose Prevention Trainers
  • 54. 54 Available resources • Naloxone kits (free from NYSDOH) • Sample policies and procedures • Approved curriculum • Fact sheets • Sample medical history • Certificates of completion • OD reporting form
  • 55. 55 Conclusions • Many overdoses can be prevented • Ask about risk factors and educate patients • Overdose training consists of a few basic components • Integrate into intake, medical visits and patient care • Drug users, friends, and family can learn to prevent and safely treat overdose • Goals: • Overdose training as standard of care • Naloxone available over the counter
  • 56. 56 RESOURCES • Harm Reduction Coalition (harmreduction.org) NYSDOH(www.health.state.ny.us - search for overdose) • On-line CASAC training and credit – www.oasas.state.ny.us
  • 57. Harm Reduction Coalition stancliff@harmreduction.org 212-213-6376 ext 39 matthews@harmreduction.org ext 38 57

Editor's Notes

  1. The transition from sniffing to injection is significant because injection is an important risk factor for HIV. In March 2003, the NEW YORK TIMES reported increases in heroin use among whites and Hispanics, with less of an increase among blacks. Frank, B. An overview of heroin trends in New York City: Past, present and future. Mt. Sinai Journal of Medicine. 2000 Oct-Nov; 67(5-6):340-6. Neaigus A, Miller M, Friedman SR., Hagen DL., Sifaneck SJ., Ildefonso G &amp; Des Jarlais DC. Potential risk factors for the transition to injecting among non-injecting heroin users: A comparison of former injectors and never injectors. Addiction 1996; (6): 847-860, 2001.
  2. Unfortunately, the reduction in overdose deaths involving heroin, has been overshadowed by a dramatic increase in overdose death from prescription opioids and the total number of overdose deaths has continued to climb. In 2006, the Allegheny County Medical Examiner reported a total of 252 overdose deaths. Pittsburgh City EMS responded to 735 overdose calls, a 51% increase over the previous year. (County wide, there were 2,608 overdose calls to 911 in 2006. )
  3. While we initially thought this drop in heroin overdose might be explained by a reduction of heroin USE, anecdotal reports and data from the Pennsylvania Department of Health, actually indicate an INCREASE in heroin use in Allegheny County over the past 6 years.